Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside

Sun Pharma has been beating industry growth in domestic formulation for two consecutive years, driven by product introductions and market share gains in existing products, adds the brokerage.